Search Results - "Sturkenboom, M. C."

Refine Results
  1. 1

    Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study by Noordam, Raymond, Aarts, Nikkie, Verhamme, Katia M., Sturkenboom, Miriam C. M., Stricker, Bruno H., Visser, Loes E.

    Published in European journal of clinical pharmacology (01-03-2015)
    “…Purpose Antidepressant drug use increases worldwide. It is pivotal to closely monitor the use of antidepressants and to determine in what subpopulations the…”
    Get full text
    Journal Article
  2. 2

    Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials by Salvo, F, Fourrier‐Réglat, A, Bazin, F, Robinson, P, Riera‐Guardia, N, Haag, M, Caputi, AP, Moore, N, Sturkenboom, MC, Pariente, A

    Published in Clinical pharmacology and therapeutics (01-06-2011)
    “…As part of the Safety of Non‐Steroidal Anti‐Inflammatory Drugs (SOS) Project, we reviewed the incidence of cardiovascular (CV) and gastrointestinal (GI) events…”
    Get full text
    Journal Article
  3. 3

    The incidence of complex regional pain syndrome: A population-based study by de Mos, M., de Bruijn, A.G.J., Huygen, F.J.P.M., Dieleman, J.P., Stricker, B.H.Ch, Sturkenboom, M.C.J.M.

    Published in Pain (Amsterdam) (01-05-2007)
    “…The complex regional pain syndrome (CRPS) is a painful disorder that can occur in an extremity after any type of injury, or even spontaneously. Data on the…”
    Get full text
    Journal Article
  4. 4

    The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and the Netherlands is levelling off by Masclee, G. M. C., Coloma, P. M., Wilde, M., Kuipers, E. J., Sturkenboom, M. C. J. M.

    Published in Alimentary pharmacology & therapeutics (01-06-2014)
    “…Summary Background Barrett's oesophagus (BO) is a risk factor for oesophageal adenocarcinoma (OAC). Several studies report increasing incidences of BO with…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project by de Bie, Sandra, Ferrajolo, Carmen, Straus, Sabine M J M, Verhamme, Katia M C, Bonhoeffer, Jan, Wong, Ian C K, Sturkenboom, Miriam C J M

    Published in PloS one (19-06-2015)
    “…Individual case safety reports (ICSRs) are a cornerstone in drug safety surveillance. The knowledge on using these data specifically for children is limited…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Medical history and the onset of complex regional pain syndrome (CRPS) by de Mos, M., Huygen, F.J.P.M., Dieleman, J.P., Koopman, J.S.H.A., Stricker, B.H.Ch, Sturkenboom, M.C.J.M.

    Published in Pain (Amsterdam) (15-10-2008)
    “…Knowledge concerning the medical history prior to the onset of complex regional pain syndrome (CRPS) might provide insight into its risk factors and potential…”
    Get full text
    Journal Article
  10. 10

    Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs by Laheij, Robert J. F, Sturkenboom, Miriam C. J. M, Hassing, Robert-Jan, Dieleman, Jeanne, Stricker, Bruno H. C, Jansen, Jan B. M. J

    “…CONTEXT Reduction of gastric acid secretion by acid-suppressive therapy allows pathogen colonization from the upper gastrointestinal tract. The bacteria and…”
    Get full text
    Journal Article
  11. 11

    Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT) by Risselada, R, Lingsma, H. F, Bauer-Mehren, A, Friedrich, C. M, Molyneux, A. J, Kerr, R. S. C, Yarnold, J, Sneade, M, Steyerberg, E. W, Sturkenboom, M. C. J. M

    Published in European journal of epidemiology (01-04-2010)
    “…Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating event with substantial case-fatality. Our purpose was to examine which clinical and neuro-imaging…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Fluoroquinolones and risk of Achilles tendon disorders: case-control study by van der Linden, P D, Sturkenboom, M C J M, Herings, R M C, Leufkens, H G M, Stricker, B H Ch

    Published in BMJ (01-06-2002)
    “…The cohort included 46 776 users of fluoroquinolones between 1 July 1992 and 30 June 30 1998, of whom 704 had Achilles tendinitis and 38 had Achilles tendon…”
    Get full text
    Journal Article
  14. 14

    Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures by Lapi, F., Cipriani, F., Caputi, A. P., Corrao, G., Vaccheri, A., Sturkenboom, M. C., Di Bari, M., Gregori, D., Carle, F., Staniscia, T., Vestri, A., Brandi, M., Fusco, V., Campisi, G., Mazzaglia, G.

    Published in Osteoporosis international (01-02-2013)
    “…Summary There is evidence that the use oral bisphosphonates can lead to osteronecrosis of the jaws (ONJ). Although the occurrence of ONJ appears rare among…”
    Get full text
    Journal Article
  15. 15

    Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons by Voordouw, A. C. G, Sturkenboom, M. C. J. M, Dieleman, J. P, Stijnen, Th, Smith, D. J, van der Lei, J, Stricker, Bruno H. Ch

    “…CONTEXT Although large-scale observational studies have demonstrated the effectiveness of influenza vaccination, no large studies have systematically addressed…”
    Get full text
    Journal Article
  16. 16

    Persistence and adherence to proton pump inhibitors in daily clinical practice by VAN SOEST, E. M., SIERSEMA, P. D., DIELEMAN, J. P., STURKENBOOM, M. C. J. M., KUIPERS, E. J.

    Published in Alimentary pharmacology & therapeutics (01-07-2006)
    “…Summary Background Proton pump inhibitors are widely used, but little is known about the usage pattern in different indications. Aim To analyse proton pump…”
    Get full text
    Journal Article
  17. 17

    Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project by Verhamme, K.M.C, Dieleman, J.P, Bleumink, G.S, van der Lei, J, Sturkenboom, M.C.J.M

    Published in European urology (01-10-2002)
    “…Objective: Benign prostatic hyperplasia (BPH) is one of the most common conditions associated with ageing in men. BPH often presents as lower urinary tract…”
    Get full text
    Journal Article
  18. 18

    The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS by de Mos, M., Huygen, F.J.P.M., Stricker, B.H.Ch, Dieleman, J.P., Sturkenboom, M.C.J.M.

    Published in Pain (Amsterdam) (01-04-2009)
    “…Antihypertensive drugs interact with mediators that are also involved in complex regional pain syndrome (CRPS), such a neuropeptides, adrenergic receptors, and…”
    Get full text
    Journal Article
  19. 19

    Cyclo‐oxygenase‐2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? by Masclee, G. M. C., Valkhoff, V. E., Soest, E. M., Schade, R., Mazzaglia, G., Molokhia, M., Trifirò, G., Goldstein, J. L., Hernández‐Díaz, S., Kuipers, E. J., Sturkenboom, M. C. J. M.

    Published in Alimentary pharmacology & therapeutics (01-07-2013)
    “…Summary Background Two strategies for prevention of upper gastrointestinal (UGI) events for nonselective nonsteroidal anti‐inflammatory drug (nsNSAID) users…”
    Get full text
    Journal Article
  20. 20

    Adherence to gastroprotection and the risk of NSAID‐related upper gastrointestinal ulcers and haemorrhage by VAN SOEST, E. M., STURKENBOOM, M. C. J. M., DIELEMAN, J. P., VERHAMME, K. M. C., SIERSEMA, P. D., KUIPERS, E. J.

    Published in Alimentary pharmacology & therapeutics (15-07-2007)
    “…Summary Background  Upper gastrointestinal (UGI) complications are a well‐recognized risk of NSAID treatment, requiring preventive measures in high‐risk…”
    Get full text
    Journal Article